Your browser doesn't support javascript.
loading
Lassa fever outcomes and prognostic factors in Nigeria (LASCOPE): a prospective cohort study.
Duvignaud, Alexandre; Jaspard, Marie; Etafo, Ijeoma Chukwudumebi; Gabillard, Delphine; Serra, Béatrice; Abejegah, Chukwuyem; le Gal, Camille; Abidoye, Abiodun Tolani; Doutchi, Mahamadou; Owhin, Sampson; Séri, Benjamin; Vihundira, Jackson Katembo; Bérerd-Camara, Marion; Schaeffer, Justine; Danet, Nicolas; Augier, Augustin; Ogbaini-Emovon, Ephraim; Salam, Alex Paddy; Ahmed, Liasu Adeagbo; Duraffour, Sophie; Horby, Peter; Günther, Stephan; Adedosu, Akinola Nelson; Ayodeji, Oladele Oluwafemi; Anglaret, Xavier; Malvy, Denis.
Afiliación
  • Duvignaud A; Inserm 1219, University of Bordeaux, and French National Research Institute for Sustainable Development, Bordeaux, France; Department of Infectious Diseases and Tropical Medicine, Division of Tropical Medicine and Clinical International Health, University Hospital Centre of Bordeaux, Hôpital Pellegr
  • Jaspard M; Inserm 1219, University of Bordeaux, and French National Research Institute for Sustainable Development, Bordeaux, France; Programme PAC-CI/ANRS Research Site, University Hospital Centre of Treichville, Abidjan, Côte d'Ivoire; The Alliance for International Medical Action, Dakar, Senegal.
  • Etafo IC; Lassa Fever Response Team, Infection Control and Research Centre, Federal Medical Centre Owo, Owo, Nigeria.
  • Gabillard D; Inserm 1219, University of Bordeaux, and French National Research Institute for Sustainable Development, Bordeaux, France; Programme PAC-CI/ANRS Research Site, University Hospital Centre of Treichville, Abidjan, Côte d'Ivoire.
  • Serra B; Inserm 1219, University of Bordeaux, and French National Research Institute for Sustainable Development, Bordeaux, France; Programme PAC-CI/ANRS Research Site, University Hospital Centre of Treichville, Abidjan, Côte d'Ivoire; The Alliance for International Medical Action, Dakar, Senegal.
  • Abejegah C; Lassa Fever Response Team, Infection Control and Research Centre, Federal Medical Centre Owo, Owo, Nigeria.
  • le Gal C; Inserm 1219, University of Bordeaux, and French National Research Institute for Sustainable Development, Bordeaux, France; Programme PAC-CI/ANRS Research Site, University Hospital Centre of Treichville, Abidjan, Côte d'Ivoire; The Alliance for International Medical Action, Dakar, Senegal.
  • Abidoye AT; Lassa Fever Response Team, Infection Control and Research Centre, Federal Medical Centre Owo, Owo, Nigeria.
  • Doutchi M; The Alliance for International Medical Action, Dakar, Senegal; Department of Infectious Diseases, National Hospital Centre of Zinder, Zinder, Niger.
  • Owhin S; Lassa Fever Response Team, Infection Control and Research Centre, Federal Medical Centre Owo, Owo, Nigeria.
  • Séri B; Inserm 1219, University of Bordeaux, and French National Research Institute for Sustainable Development, Bordeaux, France; Programme PAC-CI/ANRS Research Site, University Hospital Centre of Treichville, Abidjan, Côte d'Ivoire.
  • Vihundira JK; The Alliance for International Medical Action, Dakar, Senegal.
  • Bérerd-Camara M; The Alliance for International Medical Action, Dakar, Senegal.
  • Schaeffer J; The Alliance for International Medical Action, Dakar, Senegal.
  • Danet N; The Alliance for International Medical Action, Dakar, Senegal.
  • Augier A; The Alliance for International Medical Action, Dakar, Senegal.
  • Ogbaini-Emovon E; Institute of Lassa Fever Research and Control, Irrua Specialist Teaching Hospital, Irrua, Nigeria.
  • Salam AP; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Ahmed LA; Department of Family Medicine, Federal Medical Centre Owo, Owo, Nigeria.
  • Duraffour S; Department of Virology, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany; German Center for Infection Research, Partner Site Hamburg-Lübeck-Borstel-Riems, Hamburg, Germany.
  • Horby P; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Günther S; Department of Virology, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany; German Center for Infection Research, Partner Site Hamburg-Lübeck-Borstel-Riems, Hamburg, Germany.
  • Adedosu AN; Viral Hemorrhagic Fever Laboratory, Infection Control and Research Centre, Federal Medical Centre Owo, Owo, Nigeria.
  • Ayodeji OO; Lassa Fever Response Team, Infection Control and Research Centre, Federal Medical Centre Owo, Owo, Nigeria.
  • Anglaret X; Inserm 1219, University of Bordeaux, and French National Research Institute for Sustainable Development, Bordeaux, France; Programme PAC-CI/ANRS Research Site, University Hospital Centre of Treichville, Abidjan, Côte d'Ivoire.
  • Malvy D; Inserm 1219, University of Bordeaux, and French National Research Institute for Sustainable Development, Bordeaux, France; Department of Infectious Diseases and Tropical Medicine, Division of Tropical Medicine and Clinical International Health, University Hospital Centre of Bordeaux, Hôpital Pellegr
Lancet Glob Health ; 9(4): e469-e478, 2021 04.
Article en En | MEDLINE | ID: mdl-33740408

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cuidados Paliativos / Ribavirina / Fiebre de Lassa / Virus Lassa Tipo de estudio: Diagnostic_studies / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies País/Región como asunto: Africa Idioma: En Revista: Lancet Glob Health Año: 2021 Tipo del documento: Article Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cuidados Paliativos / Ribavirina / Fiebre de Lassa / Virus Lassa Tipo de estudio: Diagnostic_studies / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies País/Región como asunto: Africa Idioma: En Revista: Lancet Glob Health Año: 2021 Tipo del documento: Article Pais de publicación: Reino Unido